Table 1 Characteristics of the study participants classified by obesity status.

From: Association between non-alcoholic fatty liver disease and coronary calcification depending on sex and obesity

 

All participants (n = 7259)

Obese participants (n = 2839)

Non-obese participants (n = 4420)

P-value

Age (years)

54 (48–60)

54 (48–61)

54 (48–60)

0.051

Sex (male)

4309 (59.4)

2070 (72.9)

2239 (50.7)

<0.001

Hypertension (yes)

1462 (20.1)

812 (28.6)

650 (14.7)

<0.001

Diabetes (yes)

402 (5.5)

180 (6.3)

222 (5.0)

0.018

Dyslipidaemia (yes)

586 (8.1)

276 (9.7)

310 (7.0)

<0.001

Current smoker (yes)

1026 (19.8)

453 (21.7)

573 (18.5)

0.005

Alcohol status (yes)

3143 (43.3)

1376 (66.0)

1769 (56.8)

<0.001

BMI (kg/m2)

24.1 (22.0–26.3)

27.0 (25.9–28.8)

22.5 (20.9–23.8)

<0.001

SBP (mmHg)

125 (114–135)

130 (120–139)

121 (111–132)

<0.001

Fasting glucose (mg/dL)

97 (90–106)

100 (93–111)

95 (88–103)

<0.001

eGFR (mL/min/1.73 m2)

95 (84–103)

94 (82–102)

96 (85–104)

<0.001

LDL-cholesterol (mg/dL)

128 (106–153)

131 (108–158)

126 (104–149)

<0.001

CRP (mg/L)

0.7 (0.3–1.5)

1.0 (0.5–2.0)

0.5 (0.3–1.1)

<0.001

AST (IU/L)

24 (20–30)

26 (21–33)

23 (19–29)

<0.001

ALT (IU/L)

23 (16–32)

28 (20–40)

20 (15–28)

<0.001

γ-GT (IU/L)

24 (16–39)

31 (21–50)

20 (14–31)

<0.001

NAFLD (yes)

3328 (45.8)

1974 (69.5)

1354 (30.6)

<0.001

No steatosis

3931 (54.2)

864 (22.0)

3066 (78.0)

 

Mild steatosis

1604 (22.1)

771 (48.1)

833 (51.9)

 

Mild to moderate steatosis

284 (3.9)

164 (57.7)

120 (42.3)

 

Moderate steatosis

1054 (14.5)

720 (68.3)

334 (31.7)

 

Moderate to severe steatosis

171 (2.4)

131 (76.6)

40 (23.4)

 

Severe steatosis

215 (2.9)

188 (87.4)

27 (12.6)

 

Abdominal obesity (yes)

4698 (64.6)

2648 (93.3)

2050 (46.4)

<0.001

CAC (yes)

2231 (30.7)

1087 (38.3)

1144 (25.9)

<0.001

  1. Values are expressed as number (%) for categorical variables or as median (25th to 75th percentile) for numeric variables, unless noted otherwise. BMI, body mass index; SBP, systolic blood pressure; eGFR, estimated glomerular filtration rate; LDL, low-density lipoprotein; CRP, C-reactive protein; AST, aspartate aminotransferase; ALT, alanine aminotransferase; γ-GT, gamma-glutamyl transpeptidase; NAFLD, non-alcoholic fatty liver disease; CAC, coronary artery calcification.